The findings revealed that the Vitamin D Receptor (VDR) and RORs were localized in both the nucleus and cytoplasm, with their expression levels significantly reduced in primary and metastatic ovarian cancers compared to normal ovarian epithelium. This evidence concerns the gene VDR and ovarian carcinoma.